| SDAX P-IN. | 11,149.04 / -0.51% |
News
- PTA-News: S&T AG: Commentary on the share sales of June 13, 2019
06/17/2019 / 18:45 - pressetext - PTA-News: S&T AG: Third purchase offer for free-float shareholders of Kontron S&T AG at a price of EUR 4.85 per share
06/17/2019 / 12:00 - pressetext - PTA-News: S&T AG: S&T AG takes over Kapsch CarrierCom and Kapsch PublicTransportCom
05/23/2019 / 09:30 - pressetext - PTA-News: Medigene AG: Medigene announces dosing of first patient in Phase I/II trial with TCR therapy MDG1011 for various blood cancers
02/26/2019 / 12:36 - pressetext - PTA-Adhoc: Medigene AG: Medigene announces dosing of first patient in Phase I/II trial with TCR therapy MDG1011 for various blood cancers
02/26/2019 / 12:35 - pressetext - PTA-News: Medigene AG: Medigene presents development strategies for TCR therapies at CAR-TCR Summit Europe
02/26/2019 / 07:30 - pressetext - PTA-News: Medigene AG: European Patent covering TCR library suitable for the development of neoantigen-specific TCRs
02/25/2019 / 07:30 - pressetext - PTA-News: Medigene AG: Medigene participates at upcoming conferences
02/22/2019 / 07:30 - pressetext - PTA-News: Medigene AG: Medigene appoints Axel-Sven Malkomes as CFO/CBDO
02/11/2019 / 07:30 - pressetext - PTA-News: Medigene AG: Medigene participates at four upcoming conferences
01/17/2019 / 07:30 - pressetext - PTA-News: Medigene AG: Additional European patent granted for Medigene's DC vaccine platform
01/08/2019 / 17:35 - pressetext - PTA-Adhoc: Medigene AG: Medigene publishes topline interim data from ongoing Phase I/II clinical trial with DC vaccines in AML patients
12/19/2018 / 21:40 - pressetext - PTA-News: Medigene AG: Medigene participates at further upcoming conferences
12/18/2018 / 07:30 - pressetext - PTA-News: Medigene AG: Medigene participates at further upcoming conferences
11/20/2018 / 07:30 - pressetext - PTA-Adhoc: Medigene AG: Medigene Signs Exclusive License Agreement with Leiden University to Develop Novel T Cell Receptor
11/12/2018 / 18:50 - pressetext
Real-time